Yaotang Biology

About:

Yaotang Bio is a biotechnology company focusing on combining LNP delivery and gene editing technology.

Website: https://www.yoltx.com/

Top Investors: K2VC, Decheng Capital, Guangzhou Industrial Investment Group, UnityVC, Grand Flight Investment

Description:

Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, and innovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.

Total Funding Amount:

200M CNY

Headquarters Location:

Minhang, Shanghai, China

Founded Date:

2021-07-01

Contact Email:

info(AT)yoltx.com

Founders:

Number of Employees:

Last Funding Date:

2023-11-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai